Sava

Private

LondonHealthcare & Life Scienceshttps://www.sava.health/

Last Round

Series A

Jul 31, 2025

Est. Valuation

$32M

Total Funding Raised

$33.39M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Sava is a healthtech company developing a wearable biosensor platform for real-time, multi-molecule health monitoring, with its first product being a continuous glucose monitor (CGM).

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Healthcare Analytics, Vertical SaaS

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Keywords

continuous glucose monitorCGMwearable biosensorchronic disease managementdigital health platformremote patient monitoringRPMcare coordinationhealth techD2C healthpersonalized caremedical devicepopulation healthconnected health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sava Comps

Public and private peers based on sector, stage, and business model.

Sava comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sava Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jul 31, 2025
Seed	Jun 21, 2024
Seed	Jun 1, 2020
Grant	Sep 1, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Rafaël Michali

Co-Founder Co-CEO

Founding Team

Renato Circi

Co-Founder Co-CEO

Founding Team

Sava Investors

Notable investors and investment history

Sava investors
Investor	Rounds
Innovate UK	Grant
True	Series A
Solo Investments	Series A
Athletico Ventures	Series A
Solo Investments Holdings	Series A
Koinos Capital SGR	Series A
Exceptional Ventures	Seed, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 24, 2026
Grew 15% QoQ, from 126 to 145 employees.
Jan 1, 2026
Global team size now exceeds 80 members.

View all signals

Sava Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Sava Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sava's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range145

Year Founded2019

Last FundingJul 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.